Exact Mass: 809.355712

MA 144 Y

C42H51NO15 (809.3258536)

D000970 - Antineoplastic Agents D007155 - Immunologic Factors

Aclacinomycin B

C42H51NO15 (809.3258536)

D000970 - Antineoplastic Agents D007155 - Immunologic Factors

Aclacinomycin Y

C42H51NO15 (809.3258536)

D000970 - Antineoplastic Agents D007155 - Immunologic Factors

Aclacinomycin B

C42H51NO15 (809.3258536)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents D007155 - Immunologic Factors

Oligostatin C

C31H55NO23 (809.316472)

C38H51NO18

C38H51NO18 (809.3105986)

teuvisside B

C38H51NO18 (809.3105986)

Cinerubin R

C42H51NO15 (809.3258536)

Rifamexil

C42H55N3O11S (809.355712)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D012294 - Rifamycins C254 - Anti-Infective Agent > C258 - Antibiotic

(1R,2R,4S)-2-ethyl-2,7-dihydroxy-1-(methoxycarbonyl)-6,11-dioxo-4-{[2,3,6-trideoxy-4-O-{2,6-dideoxy-4-O-[(2R,6S)-6-methyl-5-oxo-5,6-dihydro-2H-pyran-2-yl]-alpha-L-lyxo-hexopyranosyl}-3-(dimethylazaniumyl)-alpha-L-lyxo-hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydrotetracen-5-olate

C42H51NO15 (809.3258536)

2-[3-[(3S,3S,4R,6S,8R,8aR)-8-[1-azocanyl(oxo)methyl]-6-(4-hydroxyphenyl)-1,2-dioxo-3,4-diphenyl-5-spiro[1H-indole-3,7-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]yl]prop-2-ynyl]propanedioic acid dimethyl ester

C48H47N3O9 (809.3312132000001)

N-[(4E,8E,12E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxytetradeca-4,8,12-trien-2-yl]pentanamide

C37H63NO18 (809.4044938)

N-[(4E,8E,12E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxypentadeca-4,8,12-trien-2-yl]butanamide

C37H63NO18 (809.4044938)

N-[(4E,8E,12E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyhexadeca-4,8,12-trien-2-yl]propanamide

C37H63NO18 (809.4044938)

N-[(4E,8E,12E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptadeca-4,8,12-trien-2-yl]acetamide

C37H63NO18 (809.4044938)

methyl (1R,2R,4S)-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-4-{[2,3,6-trideoxy-4-O-{2,6-dideoxy-4-O-[(2R,6S)-6-methyl-5-oxo-5,6-dihydro-2H-pyran-2-yl]-alpha-L-lyxo-hexopyranosyl}-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate

C42H51NO15 (809.3258536)

D000970 - Antineoplastic Agents D007155 - Immunologic Factors

aclacinomycin Y zwitterion

C42H51NO15 (809.3258536)

A zwitterion obtained by transfer of a proton from the 5-hydroxy to the tertiary amino group of aclacinomycin Y. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

Aclacinomycin y

C42H51NO15 (809.3258536)

An anthracycline antibiotic that is aclacinomycin A in which the ketone function on the trisaccharide fragment has undergone 2,3-dehydrogenation to afford the corresponding enone.

methyl (1r,2r,4s)-4-{[(2r,4s,5s,6s)-5-{[(1r,3r,5s,8r,10s,12r,14s)-5,14-dimethyl-6-oxo-2,4,9,13-tetraoxatricyclo[8.4.0.0³,⁸]tetradecan-12-yl]oxy}-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

C42H51NO15 (809.3258536)

2-[17-(3-aminopropyl)-11-benzyl-5-[(5-chloro-1h-indol-3-yl)methyl]-3,6,9,12,15,18-hexahydroxy-8,14-diisopropyl-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),3,6,9,12,15-hexaen-2-yl]-2-hydroxyethanimidic acid

C39H52ClN9O8 (809.3627182)

methyl 4-{[4-(dimethylamino)-6-methyl-5-({6-methyl-5-[(6-methyl-5-oxo-2,6-dihydropyran-2-yl)oxy]oxan-2-yl}oxy)oxan-2-yl]oxy}-2-ethyl-2,5,7,10-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

C42H51NO15 (809.3258536)

4-acetylaminoethylphenyl-1-o-[6-o-(z)-p-meth-oxycinnamoyl-β-d-glucopyranosyl(1→2)]-[β-d-glucopyranosyl(1→3)]-α-l-rhamnopyrano-side

C38H51NO18 (809.3105986)

{"Ingredient_id": "HBIN010167","Ingredient_name": "4-acetylaminoethylphenyl-1-o-[6-o-(z)-p-meth-oxycinnamoyl-\u03b2-d-glucopyranosyl(1\u21922)]-[\u03b2-d-glucopyranosyl(1\u21923)]-\u03b1-l-rhamnopyrano-side","Alias": "NA","Ingredient_formula": "C38H51NO18","Ingredient_Smile": "CC1C(C(C(C(O1)OC2=CC=C(C=C2)CCNC(=O)C)OC3C(C(C(C(O3)COC(=O)C=CC4=CC=C(C=C4)OC)O)O)O)OC5C(C(C(C(O5)CO)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "313","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

n-[2-(4-{[(2s,3r,4r,5s,6s)-5-hydroxy-6-methyl-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2z)-3-(4-methoxyphenyl)prop-2-enoyl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl]oxy}phenyl)ethyl]ethanimidic acid

C38H51NO18 (809.3105986)

methyl (1r,2s,4s)-4-{[(2s,4s,5r,6s)-4-(dimethylamino)-5-{[(2r,4s,5r,6r)-4-hydroxy-6-methyl-5-{[(2r,6r)-6-methyl-5-oxo-2,6-dihydropyran-2-yl]oxy}oxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

C42H51NO15 (809.3258536)

methyl (1r,2r)-4-{[(2r,4s,5s,6s)-5-{[(5s,12s,14s)-5,14-dimethyl-6-oxo-2,4,9,13-tetraoxatricyclo[8.4.0.0³,⁸]tetradecan-12-yl]oxy}-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

C42H51NO15 (809.3258536)

(2s)-2-[(2s,5s,8s,11s,14s,17s)-17-(3-aminopropyl)-11-benzyl-5-[(5-chloro-1h-indol-3-yl)methyl]-3,6,9,12,15,18-hexahydroxy-8,14-diisopropyl-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),3,6,9,12,15-hexaen-2-yl]-2-hydroxyethanimidic acid

C39H52ClN9O8 (809.3627182)

(2z)-n-[2-(4-{[(2s,3r,4r,5s,6s)-5-(acetyloxy)-6-methyl-3,4-bis({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})oxan-2-yl]oxy}phenyl)ethyl]-3-(4-methoxyphenyl)prop-2-enimidic acid

C38H51NO18 (809.3105986)

(2e)-n-[2-(4-{[(2s,3r,4r,5s,6s)-5-(acetyloxy)-6-methyl-3,4-bis({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})oxan-2-yl]oxy}phenyl)ethyl]-3-(4-methoxyphenyl)prop-2-enimidic acid

C38H51NO18 (809.3105986)

methyl (1r,2r,4s)-4-{[5-({5,14-dimethyl-6-oxo-2,4,9,13-tetraoxatricyclo[8.4.0.0³,⁸]tetradecan-12-yl}oxy)-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

C42H51NO15 (809.3258536)

n-(2-{4-[(5-hydroxy-6-methyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-{[3,4,5-trihydroxy-6-({[3-(4-methoxyphenyl)prop-2-enoyl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]phenyl}ethyl)ethanimidic acid

C38H51NO18 (809.3105986)

n-[2-(4-{[(2s,3r,4s,5r,6r)-5-hydroxy-6-methyl-4-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-({[(2z)-3-(4-methoxyphenyl)prop-2-enoyl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl]oxy}phenyl)ethyl]ethanimidic acid

C38H51NO18 (809.3105986)

n-[2-(4-{[(2s,3r,4r,5s,6s)-5-(acetyloxy)-6-methyl-3,4-bis({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})oxan-2-yl]oxy}phenyl)ethyl]-3-(4-methoxyphenyl)prop-2-enimidic acid

C38H51NO18 (809.3105986)

methyl (1r,2r,4s)-4-{[4-(dimethylamino)-6-methyl-5-({6-methyl-5-[(6-methyl-5-oxo-2,6-dihydropyran-2-yl)oxy]oxan-2-yl}oxy)oxan-2-yl]oxy}-2-ethyl-2,5,7,10-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

C42H51NO15 (809.3258536)

methyl (1r,2r)-4-{[(2r,4s,5s,6s)-5-{[(1r,3r,5s,8s,10s,12s,14s)-5,14-dimethyl-6-oxo-2,4,9,13-tetraoxatricyclo[8.4.0.0³,⁸]tetradecan-12-yl]oxy}-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

C42H51NO15 (809.3258536)

(2s,3r,4r,6r)-6-methoxy-2-methyl-3-(methylsulfanyl)oxan-4-ol; (2s,3r,4r,6s)-6-methoxy-2-methyl-3-(methylsulfanyl)oxan-4-ol; n-[2-({[(2s,3r,4s)-3-hydroxy-6-methoxy-2-methyloxan-4-yl]oxy}carbonyl)-4,5-dimethoxyphenyl]-2-methoxyprop-2-enimidic acid

C36H59NO15S2 (809.3325944000001)